AVTR Avantor, Inc.
XNYS 16.74 +0.36% Pre-marketStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
AVTR
$16.74
▲ +0.36%
Key stats
$16.68
Pre-market
$16.74
+0.36%
- 52-Week Range
- $7.26 – $17.45
- YTD
- +45.55%
- IV Rank (30D)
- 15.15
- Straddle Price
- $1.25
- P/C Vol Ratio
- 0.69
- Market Cap
- $11.3B
- Open
- $16.64
- Day Range
- $16.32 – $16.73
- Volume
- 11,218,024
- Prev Close
- $16.69
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.99% |
| Beta vs SPY | 0.90 |
| Cost of Equity (CAPM) | 9.47% (VRP-adj) |
| WACC | 8.48% |
| Volatility Risk Premium | +121.8pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +2.1% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.02 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.4B |
| Return on Equity (TTM) | 5.8% |
| Book / Price | 51.6% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 31.6% |
| FCF Margin (TTM) | 6.6% |
| Debt / Equity | 0.63 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| Market-Implied Growth | +18.3% (reverse-DCF on current price) |
| SMA 50 | $15.45 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $16.23 |
| Bollinger Width / SMA20 | 108.9% (drives anchor stability) |
| Net Debt | $3.2B |
| Market Cap | $11B |
Peers used for multiples: AROC, ARW, MOG.A, R, RGA, TDY
(filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
30%
20-Day Fair Value
≈ by Nov 30, 2026
$16.75
α +0.4%
rank 34%
conviction
26%
40-Day Fair Value
≈ by Dec 29, 2026
$17.03
α +2.1%
rank 21%
conviction
68%
60-Day Fair Value
≈ by Jan 27, 2027
$16.83
α +0.9%
rank 18%
conviction
30%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $6.21 | 23% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $9.54 | 7% | median 18.7× · 6 peers |
| Peer EV/EBITDA | $7.70 | 7% | median 9.0× · 6 peers |
| Peer P/B | $27.16 | 7% | median 3.2× · 6 peers |
| Peer P/S | $16.79 | 7% | median 1.7× · 6 peers |
| Market Anchor (SMA50) | $15.45 | 38% | stability 83% (BB-width) |
| Options Expected (B-L 30d) | $17.48 | 12% | 11 strikes · skew +0.67 |
As of 2026-10-30 · updated
Related
About
- Industry (SIC)
- LABORATORY ANALYTICAL INSTRUMENTS (3826) · industry map
- Exchange
- XNYS
- Market Cap
- $11.3B
- Employees
- 13,500
- List Date
- 2019-05-17
- CIK
- 0001722482
- Headquarters
- Radnor, PA
- Homepage
- https://www.avantorsciences.com
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab sup…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 7.98% | -7.96% | 12.90% | 1.05% | 5.09% | -4.71% | 2.39% |
| Feb | -5.53% | -8.73% | -0.25% | 4.58% | -23.64% | -18.25% | -8.64% |
| Mar | 1.62% | -1.17% | -13.93% | 2.28% | 2.14% | -11.01% | -3.35% |
| Apr | 8.79% | -6.76% | -6.17% | -4.00% | -17.78% | 4.25% | -3.61% |
| May | 2.81% | 1.91% | -1.43% | -1.39% | -0.39% | 14.57% | 2.68% |
| Jun | 13.27% | -2.60% | 3.22% | -12.61% | 3.86% | 7.73% | 2.15% |
| Jul | 3.78% | -8.19% | 1.18% | 28.79% | -3.45% | 35.70% | 9.63% |
| Aug | 4.89% | -15.53% | 3.64% | -2.49% | 18.57% | 6.36% | 2.57% |
| Sep | 2.48% | -21.38% | -2.86% | 2.99% | -6.09% | 5.99% | -3.14% |
| Oct | -2.82% | -0.20% | -16.40% | -12.00% | -13.53% | 10.98%* | -5.66% |
| Nov | -0.20% | 11.51% | 21.65% | -5.60% | 0.43% | -- | 5.56% |
| Dec | 10.05% | -7.50% | 6.78% | -0.14% | -2.47% | -- | 1.34% |
| Total | 56.37% | -51.77% | 2.36% | -4.06% | -36.52% | 51.44% | 2.97% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $16.23
SMA 50: $15.45
SMA 200: $11.18
Current: $16.68
EMA 12: $16.66
EMA 26: $16.15
MACD: 0.5145 | Signal: 0.0120
BULLISH
ADX (14): 38.64
TREND
+DI: 25.22
−DI: 18.45
Momentum Oscillators
RSI (14): 59.99
NEUTRAL
Stoch %K: 70.96
Stoch %D: 81.22
Williams %R: -37.38
Volume & Volatility
BB Upper: $17.67
BB Lower: $14.80
NEUTRAL
OBV: -174,462,831
Vol SMA 20: 10,556,128
Vol ROC: 87.94%
ATR: $0.51
True Range: $0.41
HV 20: 27.6%
HV 30: 28.9%
HV 60: 28.7%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-31T00:00:00 – 2026-10-29T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Moderate volatility, following market trends
- Recent negative news sentiment, primarily driven by legal issues and investor losses
Primary Risks:
- Potential for further declines due to ongoing regulatory challenges and investor skepticism
- Need for a strong earnings report or positive catalysts to drive price recovery
Investment Thesis: AVTR is likely to remain in a sideways trend until the company addresses its legal and regulatory concerns. A strong earnings report or a favorable resolution to these issues could trigger a rebound.
Recent News Sentiment Impact:
The negative news headlines regarding legal issues and investor losses have contributed to the stock's recent decline. However, the neutral tone of some recent articles suggests that investors are starting to focus on the company's underlying fundamentals rather than just reacting to short-term news shocks.
Technical Analysis
Trend Direction: NEUTRAL (Short-term: Sideways, Medium-term: Downward, Long-term: Unknown)
Support/Resistance Levels:
- Lower Bollinger Band: $10.88
- Middle Line: $13.04
- Upper Bollinger Band: $15.20
Momentum Signals:
- RSI (14): 63.00 (neutral)
- MACD: Bullish signal with a histogram of 0.85
- Stochastic %K and %D are trending downward, indicating potential bearish momentum
Volume Analysis:
- Volume SMA 20: 11885281.52
- On-Balance Volume (OBV): -263461897.11 (showing a decline in buying pressure)
- Volume Rate of Change: -49.79% (indicating a contraction in trading volume)
News & Sentiment Analysis
Recent Headlines Summary:
The past 10 news articles are primarily focused on legal issues and investor losses, with some neutral pieces discussing the company's underlying fundamentals.
Sentiment Assessment: NEGATIVE (Aggregate sentiment based on recent headlines)
Catalyst Identification:
- No upcoming earnings reports or significant events that could drive price movement
Market Narrative:
The negative news headlines have driven the stock's decline, but some investors are starting to focus on the company's fundamentals. A strong earnings report or a favorable resolution to the regulatory challenges could trigger a rebound.
Risk & Volatility Assessment
Risk Assessment: MODERATE (Beta: 0.92)
Volatility Regime:
- Current vs historical volatility levels: Low - moderate
Options Market Signals:
- IV Rank: 0.7% (Low)
- Current IV: 74.3%
- Expected Move: $1.47 (32 DTE), 7-DTE: $0.70
- Volume Flow: 95 calls vs 220 puts (Bearish sentiment)
Downside Protection:
- Support levels: Lower Bollinger Band and Middle Line
- Risk management considerations: Stop-loss levels and position sizing considerations
Market Context & Positioning
Sector Performance:
- AVTR is underperforming its sector peers, with a relative strength index of 45.99
Institutional Activity:
- No significant institutional activity or volume patterns suggesting institutional interest
Correlation Analysis:
- Correlation coefficient: 0.23 (Moderate correlation between stock and market)
Relative Valuation:
- AVTR is trading within its historical range, with no clear overbought or oversold conditions
Key Levels & Action Items
Critical Price Levels:
- Lower Bollinger Band: $10.88
- Middle Line: $13.04
Breakout/Breakdown Levels:
- Upper Bollinger Band: $15.20 (Potential upside target)
Time-Sensitive Catalysts:
- No upcoming earnings reports or significant events that could drive price movement
Risk Management:
- Stop-loss levels and position sizing considerations based on volatility and risk assessments
Generated
News
All AVTR news →
Ligner discusses return to organic growth and Revival program progress.
Earnings History
16 of 24 under expected move
Avg Expected Move
10.18%
Avg Actual Move
7.57%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-01-11 | Pre-Market | 5.69% | 5.10% | 0.90x | Within |
| 2021-04-28 | Pre-Market | 7.78% | 0.24% | 0.03x | Within |
| 2021-07-29 | Pre-Market | 7.36% | 0.67% | 0.09x | Within |
| 2021-10-12 | Pre-Market | 3.58% | 8.23% | 2.30x | Exceeded |
| 2022-02-03 | Pre-Market | 8.34% | 1.28% | 0.15x | Within |
| 2022-04-28 | Pre-Market | 9.72% | 1.26% | 0.13x | Within |
| 2022-07-28 | Pre-Market | 8.19% | 1.79% | 0.22x | Within |
| 2022-10-28 | Pre-Market | 10.22% | 6.43% | 0.63x | Within |
| 2023-02-03 | Pre-Market | 7.84% | 7.36% | 0.94x | Within |
| 2023-04-28 | Pre-Market | 11.26% | 3.95% | 0.35x | Within |
| 2023-07-28 | Pre-Market | 7.80% | 6.79% | 0.87x | Within |
| 2023-10-27 | Pre-Market | 9.78% | 8.66% | 0.89x | Within |
| 2024-02-14 | Pre-Market | 8.04% | 10.21% | 1.27x | Exceeded |
| 2024-04-26 | Pre-Market | 6.36% | 4.81% | 0.76x | Within |
| 2024-07-26 | Pre-Market | 7.45% | 12.18% | 1.63x | Exceeded |
| 2024-10-25 | Pre-Market | 9.24% | 3.61% | 0.39x | Within |
| 2025-02-07 | Pre-Market | 9.22% | 11.71% | 1.27x | Exceeded |
| 2025-04-25 | Pre-Market | 15.16% | 16.58% | 1.09x | Exceeded |
| 2025-08-01 | Pre-Market | 14.88% | 15.48% | 1.04x | Exceeded |
| 2025-10-29 | Pre-Market | 14.59% | 23.21% | 1.59x | Exceeded |
| 2026-02-11 | Pre-Market | 17.03% | 13.62% | 0.80x | Within |
| 2026-04-29 | Pre-Market | 19.08% | 0.13% | 0.01x | Within |
| 2026-07-29 | Pre-Market | 12.48% | 15.78% | 1.26x | Exceeded |
| 2026-10-28 | Pre-Market | 13.13% | 2.57% | 0.20x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
AVTR Options Activity & IV Rank
AVTR IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 38.4%
7-DTE IV: —
Expected Move: $1.25
7-DTE Move: $1.25
Days to Exp: 22 (2026-11-20)
Options Flow
Call Volume: 1,343
Put Volume: 929
P/C Volume: 0.692
BULLISH
Call OI: 12,246
Put OI: 17,563
P/C OI: 1.434
Total OI: 29,809
ATM Options Pricing
ATM Call: $0.47
ATM Put: $0.78
Call %: 2.8%
Put %: 4.6%
Chain Summary
Chain Volume: 8,498
Chain OI: 53,550
Last Updated: 10/29/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 58th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
58%
vs own history
GEX tilt
+0.01
OI-weighted, today
Vanna tilt
+0.50
δ-sensitivity to IV
Charm tilt
-0.62
δ-decay vs time
Vanna tilt +0.50: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.62: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 26 ATM contracts, 36k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 29 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Oct 29 · No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)15.2LowOct 29
Straddle Price (30 DTE)$1.25Oct 29
Beta Analysis
Risk Metrics
Beta: 0.7975
Alpha: 36.44%
Correlation: 0.2318
R-Squared: 5.4%
Stock Volatility: 43.7%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own AVTR
4 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $7.5M | #1801 of 3716 | -69.1% | 13F | |
| Citadel Hedge fund Ken Griffin | $4.0M | #2282 of 6285 | -29.9% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $3.0M | #592 of 997 | +134.9% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $84K | #3078 of 4729 | +171.0% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
AVTR Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 677,850,000 (as of 2026-09-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
10 filers$14.56M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | CastleKnight Management LP | $3.96M | 27.20% | 2026-06-30 |
| 2 | Simplex Trading, LLC Custodian | $2.76M | 18.96% | 2026-06-30 |
| 3 | Susquehanna International Group, LLP Custodian | $2.39M | 16.41% | 2026-06-30 |
| 4 | GROUP ONE TRADING LLC Custodian | $1.22M | 8.41% | 2026-06-30 |
| 5 | Wolverine Trading, LLC Custodian | $1.12M | 7.68% | 2025-09-30 |
| 6 | Citadel Advisors LLC Custodian | $887.04K | 6.09% | 2026-06-30 |
| 7 | IMC-Chicago, LLC Custodian | $745.47K | 5.12% | 2026-06-30 |
| 8 | Jane Street Group, LLC Custodian | $601.92K | 4.13% | 2026-06-30 |
| 9 | Loews Corp | $594.00K | 4.08% | 2026-06-30 |
| 10 | Walleye Capital LLC | $279.18K | 1.92% | 2026-06-30 |
9 filers$9.31M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $4.45M | 47.84% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $1.37M | 14.68% | 2026-06-30 |
| 3 | Susquehanna International Group, LLP Custodian | $788.04K | 8.47% | 2026-06-30 |
| 4 | Wolverine Trading, LLC Custodian | $698.56K | 7.51% | 2025-09-30 |
| 5 | IMC-Chicago, LLC Custodian | $638.55K | 6.86% | 2026-06-30 |
| 6 | Walleye Capital LLC | $510.84K | 5.49% | 2026-06-30 |
| 7 | Simplex Trading, LLC Custodian | $399.96K | 4.30% | 2026-06-30 |
| 8 | GROUP ONE TRADING LLC Custodian | $254.43K | 2.73% | 2026-06-30 |
| 9 | Walleye Trading LLC | $198.00K | 2.13% | 2026-06-30 |
AVTR Insider Trading (Form 4)
Latest: 2026-09-23Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Todd W Garner | EVP and CFO | Award (A) | +49,688 | — | EDGAR | |
| 2026-08-20 | Emmanuel Ligner | President and CEO | Tax (F) | −29,803 | $13.33 | -$397.3K | EDGAR |
| 2026-08-18 | Brittany Hankamer | EVP, Chief HR Officer | Tax (F) | −181 | $13.66 | -$2.5K | EDGAR |
| 2026-08-04 | Steven W Eck | SVP & Chief Accounting Officer | Tax (F) | −1,385 | $13.78 | -$19.1K | EDGAR |
| 2026-07-27 | Claudius Sokenu | EVP, Chief Legal & Compliance | Tax (F) | −1,201 | $11.44 | -$13.7K | EDGAR |
| 2026-06-22 | Corey Walker | President, VWR Dist. & Servs. | Tax (F) | −3,010 | $9.58 | -$28.8K | EDGAR |
| 2026-05-11 | Gregory L Summe | Director | Award (A) | +25,270 | — | EDGAR | |
| 2026-05-11 | Michael Severino | Director | Award (A) | +25,270 | — | EDGAR | |
| 2026-05-11 | Sanjeev K Mehra | Director | Award (A) | +25,270 | — | EDGAR | |
| 2026-05-11 | Joseph R Massaro | Director | Award (A) | +25,270 | — | EDGAR | |
| 2026-05-11 | Louise Makin | Director | Award (A) | +25,270 | — | EDGAR | |
| 2026-05-11 | Simon Dingemans | Director | Award (A) | +25,270 | — | EDGAR | |
| 2026-05-11 | Gregory T Lucier | Director | Mixed | +35,270 | $8.32 | $83.2K | EDGAR |
| 2026-05-11 | Mala Murthy | Director | Award (A) | +25,270 | — | EDGAR | |
| 2026-05-05 | Ludovic Brellier | EVP, Bioscience & Medtech | Award (A) | +146,566 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
AVTR Insider Holdings
25 insiders · @ $16.68
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Michael Stubblefield | President & CEO | 1,764,513 | $29.43M | -$35.20M | 27 | 2025-05-21 |
| 2 | Emmanuel Ligner | President and CEO | 737,334 | $12.30M | $993.1K | 4 | 2026-08-20 |
| 3 | Sanjeev K Mehra | Director | 508,376 | $8.48M | $4.88M | 3 | 2026-05-11 |
| 4 | Gregory L Summe | Director | 483,381 | $8.06M | $4.56M | 15 | 2026-05-11 |
| 5 | R. Brent Jones | EVP, Chief Financial Officer | 419,782 | $7.00M | $0 | 6 | 2026-02-25 |
| 6 | Corey Walker | President, VWR Dist. & Servs. | 384,535 | $6.41M | $0 | 6 | 2026-06-22 |
| 7 | Benoit Gourdier | EVP, Bioscience & Medtech | 362,859 | $6.05M | $0 | 8 | 2026-02-25 |
| 8 | Mary Blenn | EVP, Chief Operating Officer | 253,384 | $4.23M | $0 | 2 | 2026-02-23 |
| 9 | Claudius Sokenu | EVP, Chief Legal & Compliance | 251,228 | $4.19M | $0 | 9 | 2026-07-27 |
| 10 | Brittany Hankamer | EVP, Chief HR Officer | 248,864 | $4.15M | $0 | 12 | 2026-08-18 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
AVTR Board & Officers
As of SEC filings through Sep 23, 2026Directors 12
- Juan Andres · since Sep 20, 2019
- Michael Severino · since Apr 22, 2020
- Gregory L Summe · since May 7, 2020
- Lan Kang · since May 14, 2021
- John Carethers · since Jul 15, 2021
- Mala Murthy · since Oct 28, 2021
- Joseph R Massaro · since Nov 8, 2021
- Louise Makin · since Nov 4, 2024
- Emmanuel Ligner · since Aug 18, 2025
- Gregory T Lucier · since Oct 3, 2025
- Sanjeev K Mehra · since Dec 5, 2025
- Simon Dingemans · since Jan 2, 2026
Officers 9
- Emmanuel Ligner · President and CEO · since Aug 18, 2025
- Corey Walker · President, VWR Dist. & Servs. · listed since Feb 2026
- Todd W Garner · EVP and CFO · since Sep 21, 2026
- Mary Blenn · EVP, Chief Operating Officer · since Nov 10, 2025
- Steven W Eck · SVP & Chief Accounting Officer · since May 23, 2019
- Claudius Sokenu · EVP, Chief Legal & Compliance · since Jul 24, 2023
- Brittany Hankamer · EVP, Chief HR Officer · since Aug 23, 2023
- Christophe Couturier · EVP, Amea · listed since Apr 2021
- Ludovic Brellier · EVP, Bioscience & Medtech · since May 1, 2026
Changes in the last 10 years (113)
| Sep 21, 2026 | Todd W Garner became EVP and CFO |
| May 1, 2026 | Ludovic Brellier became EVP, Bioscience & Medtech |
| Apr 17, 2026 | The company announced the departure of Benoit Gourdier as EVP, Bioscience & Medtech in an SEC filing |
| Mar 26, 2026 | The company announced the departure of R. Brent Jones as EVP, Chief Financial Officer in an SEC filing |
| Feb 23, 2026 | Corey Walker listed as President, VWR Dist. & Servs. (previously President Laboratory Solutions) in SEC filings |
| Feb 23, 2026 | Benoit Gourdier listed as EVP, Bioscience & Medtech (previously EVP, Bioscience Production) in SEC filings |
| Jan 2, 2026 | Simon Dingemans became a director |
| Dec 5, 2025 | Sanjeev K Mehra became a director |
| Nov 10, 2025 | Mary Blenn became EVP, Chief Operating Officer |
| Oct 10, 2025 | The company announced the departure of Jonathan M Peacock from the board in an SEC filing |
| Oct 3, 2025 | Gregory T Lucier became a director |
| Aug 18, 2025 | Emmanuel Ligner became a director |
| Aug 18, 2025 | Emmanuel Ligner became President and CEO |
| Jul 15, 2025 | The company announced the departure of Michael Stubblefield from the board in an SEC filing |
| Jul 15, 2025 | The company announced the departure of Michael Stubblefield from the board in an SEC filing |
| Apr 24, 2025 | The company announced the departure of Michael Stubblefield as President & CEO in an SEC filing |
| Jan 6, 2025 | The company announced the departure of James Bramwell as EVP Sales, Customer Excellence in an SEC filing |
| Nov 4, 2024 | Louise Makin became a director |
| Oct 4, 2024 | Benoit Gourdier listed as EVP, Bioscience Production (previously EVP, Biopharma Production) in SEC filings |
| Jun 25, 2024 | Corey Walker listed as President Laboratory Solutions (previously Title: EVP, Americas, Biomaterials and Advanced Technologies) in SEC filings |
| Jun 21, 2024 | The company announced the departure of Randy Lee Stone as EVP, Proprietary Products in an SEC filing |
| Feb 22, 2024 | James Bramwell listed as EVP Sales, Customer Excellence (previously EVP, Americas) in SEC filings |
| Dec 1, 2023 | The company announced the departure of Sheri Lewis as EVP, Global Ops & Supply Chain in an SEC filing |
| Dec 1, 2023 | The company announced the departure of Frederic Vanderhaegen as EVP, Americas & Europe in an SEC filing |
| Oct 2, 2023 | Benoit Gourdier became EVP, Biopharma Production |
| Aug 23, 2023 | Brittany Hankamer became EVP, Chief HR Officer |
| Aug 7, 2023 | R. Brent Jones became EVP, Chief Financial Officer |
| Jul 24, 2023 | Claudius Sokenu became EVP, Chief Legal & Compliance |
| May 9, 2023 | The company announced the departure of Thomas A Szlosek as EVP & CFO in an SEC filing |
| Apr 16, 2023 | Randy Lee Stone became EVP, Proprietary Products |
| Feb 22, 2023 | Michael Stubblefield listed as President & CEO (previously CEO) in SEC filings |
| Feb 15, 2023 | James Bramwell listed as EVP, Americas (previously EVP, Strategic Partners) in SEC filings |
| Feb 14, 2023 | Kitty Sahin became EVP, Strategy&Corp Development |
| Nov 17, 2022 | Michael Stubblefield listed as CEO (previously President and CEO) in SEC filings |
| Nov 16, 2022 | The company announced the departure of Matthew S. Holt from the board in an SEC filing |
| Feb 25, 2022 | Frederic Vanderhaegen listed as EVP, Americas & Europe (previously EVP, Europe) in SEC filings |
| Feb 10, 2022 | The company announced the departure of Rajiv Gupta from the board in an SEC filing |
| Nov 8, 2021 | Joseph R Massaro became a director |
| Oct 28, 2021 | Mala Murthy became a director |
| Jul 15, 2021 | John Carethers became a director |
| May 14, 2021 | Lan Kang became a director |
| Apr 7, 2021 | Christophe Couturier listed as EVP, Amea (previously EVP, Services) in SEC filings |
| Dec 31, 2020 | Sheri Lewis became EVP, Global Ops & Supply Chain |
| Dec 31, 2020 | Meghan Henson became EVP, Chief HR Officer |
| Dec 8, 2020 | Michael Stubblefield listed as President and CEO (previously CEO) in SEC filings |
| Dec 8, 2020 | Michael Stubblefield first listed as a director in an SEC filing |
| Nov 10, 2020 | Steven B Klinsky reported in an SEC filing no longer being a 10% owner |
| Nov 10, 2020 | New Mountain Partners III LP reported in an SEC filing no longer being a 10% owner |
| Nov 10, 2020 | New Mountain Investments III, LLC reported in an SEC filing no longer being a 10% owner |
| Nov 10, 2020 | New Mountain Capital, L.L.C. reported in an SEC filing no longer being a 10% owner |
| Nov 10, 2020 | New Mountain Capital Group, L.P. reported in an SEC filing no longer being a 10% owner |
| Nov 10, 2020 | NM Holdings GP, L.L.C. reported in an SEC filing no longer being a 10% owner |
| Aug 25, 2020 | VWR Partners, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 25, 2020 | StoneBridge 2018, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 25, 2020 | StoneBridge 2018 Offshore, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 25, 2020 | StoneBridge 2017, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 25, 2020 | StoneBridge 2017 Offshore, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 25, 2020 | Goldman Sachs Group Inc reported in an SEC filing no longer being a 10% owner |
| Aug 25, 2020 | Goldman Sachs & Co. LLC reported in an SEC filing no longer being a 10% owner |
| Aug 25, 2020 | Broad Street Principal Investments, L.L.C. reported in an SEC filing no longer being a 10% owner |
| Aug 25, 2020 | Bridge Street Opportunity Advisors, L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 28, 2020 | Thomas Connolly reported in an SEC filing no longer being a director |
| May 12, 2020 | Eric McAllister listed as EVP, CHRO (previously EVP and Chief Human Resources Officer) in SEC filings |
| May 7, 2020 | Gregory L Summe became a director |
| Apr 22, 2020 | Michael Severino became a director |
| Feb 25, 2020 | Michael Stubblefield listed as CEO (previously President and CEO) in SEC filings |
| Feb 25, 2020 | Justin Miller listed as EVP & General Counsel (previously EVP, Gen. Counsel & Secretary) in SEC filings |
| Feb 25, 2020 | Christophe Couturier listed as EVP, Services (previously EVP, Services, Strategy & Business Transformation) in SEC filings |
| Feb 20, 2020 | Devashish Ohri listed as EVP, Imea (previously EVP, Amea) in SEC filings |
| Jan 21, 2020 | Sven Henrichwark became EVP, APAC Region |
| Jan 13, 2020 | Mark Christopher Murray became EVP, Biomaterials & AT |
| Sep 30, 2019 | Tanya Foxe became EVP, Operations & Supply Chain |
| Sep 20, 2019 | Juan Andres became a director |
| May 23, 2019 | Steven W Eck became SVP & Chief Accounting Officer |
| May 23, 2019 | Bridge Street Opportunity Advisors, L.L.C. first on file as a 10% owner |
| May 16, 2019 | VWR Partners, L.P. became a 10% owner |
| May 16, 2019 | Thomas Connolly became a director |
| May 16, 2019 | Thomas A Szlosek became EVP & CFO |
| May 16, 2019 | StoneBridge 2018, L.P. became a 10% owner |
| May 16, 2019 | StoneBridge 2018 Offshore, L.P. became a 10% owner |
| May 16, 2019 | StoneBridge 2017, L.P. became a 10% owner |
| May 16, 2019 | StoneBridge 2017 Offshore, L.P. became a 10% owner |
| May 16, 2019 | Steven B Klinsky became a 10% owner |
| May 16, 2019 | Robert Fine became a director |
| May 16, 2019 | Rakesh Sachdev became a director |
| May 16, 2019 | Rajiv Gupta became a director |
| May 16, 2019 | New Mountain Partners III LP became a 10% owner |
| May 16, 2019 | New Mountain Investments III, LLC became a 10% owner |
| May 16, 2019 | New Mountain Capital, L.L.C. became a 10% owner |
| May 16, 2019 | New Mountain Capital Group, L.P. became a 10% owner |
| May 16, 2019 | NM Holdings GP, L.L.C. became a 10% owner |
| May 16, 2019 | Michael Wondrasch became EVP & CIO |
| May 16, 2019 | Michael Stubblefield became a director |
| May 16, 2019 | Michael Stubblefield became President and CEO |
| May 16, 2019 | Michael DePetris became SVP and Corporate Controller |
| May 16, 2019 | Matthew S. Holt became a director |
| May 16, 2019 | Justin Miller became EVP, Gen. Counsel & Secretary |
| May 16, 2019 | Jonathan M Peacock became a director |
| May 16, 2019 | Jo Natauri became a director |
| May 16, 2019 | James Bramwell became EVP, Strategic Partners |
| May 16, 2019 | Goldman Sachs Group Inc became a 10% owner |
| May 16, 2019 | Goldman Sachs & Co. LLC became a 10% owner |
| May 16, 2019 | Gerard Brophy became EVP, Biopharma Production |
| May 16, 2019 | Frederic Vanderhaegen became EVP, Europe |
| May 16, 2019 | Eric McAllister became EVP and Chief Human Resources Officer |
| May 16, 2019 | Devashish Ohri became EVP, Amea |
| May 16, 2019 | Corey Walker became Title: EVP, Americas, Biomaterials and Advanced Technologies |
| May 16, 2019 | Christophe Couturier became EVP, Services, Strategy & Business Transformation |
| May 16, 2019 | Christi Shaw became a director |
| May 16, 2019 | Broad Street Principal Investments, L.L.C. became a 10% owner |
| May 16, 2019 | Bjorn Hofman became EVP and COO |
| May 16, 2019 | Ashish Kulkarni became EVP and Chief Technology Officer |
| May 16, 2019 | Andre V. Moura became a director |
Not reported recently (18)
- Kitty Sahin · Last reported as EVP, Strategy&Corp Development in an SEC filing dated Jul 22, 2024
- Justin Miller · Last reported as EVP & General Counsel in an SEC filing dated May 19, 2023
- Gerard Brophy · Last reported as EVP, Biopharma Production in an SEC filing dated May 19, 2023
- Christi Shaw · Last reported as a director in an SEC filing dated May 15, 2023
- Meghan Henson · Last reported as EVP, Chief HR Officer in an SEC filing dated Feb 27, 2023
- Michael Wondrasch · Last reported as EVP & CIO in an SEC filing dated Feb 22, 2023
- Mark Christopher Murray · Last reported as EVP, Biomaterials & AT in an SEC filing dated Jan 18, 2022
- Jo Natauri · Last reported as a director in an SEC filing dated Aug 13, 2021
- Devashish Ohri · Last reported as EVP, Imea in an SEC filing dated May 28, 2021
- Rakesh Sachdev · Last reported as a director in an SEC filing dated Mar 1, 2021
- Sven Henrichwark · Last reported as EVP, APAC Region in an SEC filing dated Mar 1, 2021
- Eric McAllister · Last reported as EVP, CHRO in an SEC filing dated May 19, 2020
- Tanya Foxe · Last reported as EVP, Operations & Supply Chain in an SEC filing dated Feb 25, 2020
- Ashish Kulkarni · Last reported as EVP and Chief Technology Officer in an SEC filing dated May 23, 2019
- Bjorn Hofman · Last reported as EVP and COO in an SEC filing dated May 23, 2019
- Robert Fine · Last reported as a director in an SEC filing dated May 16, 2019
- Michael DePetris · Last reported as SVP and Corporate Controller in an SEC filing dated May 16, 2019
- Andre V. Moura · Last reported as a director in an SEC filing dated May 16, 2019
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
AVTR Proposed Insider Sales (Form 144)
Latest: 2025-11-06
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2025-11-06 | Todd Edwards | officer | 29,131 | $732.9K | 2025-11-06 | Merrill | — | EDGAR |
| 2025-08-05 | Eck Steven W | Officer | 3,476 | $39.6K | 2025-08-05 | Merrill | 10b5-1 | EDGAR |
| 2025-02-27 | Bramwell James | Officer | 774 | $13.2K | 2025-02-27 | Merrill | 10b5-1 | EDGAR |
| 2025-02-27 | Eck Steven W | Officer | 1,033 | $17.6K | 2025-02-27 | Merrill | 10b5-1 | EDGAR |
| 2025-02-26 | Bramwell James | Officer | 3,758 | $65.9K | 2025-02-26 | Merrill | 10b5-1 | EDGAR |
| 2025-02-26 | Eck Steven W | Officer | 4,907 | $86.0K | 2025-02-26 | Merrill | 10b5-1 | EDGAR |
| 2024-09-05 | Eck Steven W | Officer | 3,525 | $88.3K | 2024-09-05 | Merrill | — | EDGAR |
| 2024-08-26 | Wondrasch Michael | Officer | 17,000 | $434.2K | 2024-08-26 | Merrill | — | EDGAR |
| 2024-07-31 | Couturier Christophe | Officer | 100 | $2.8K | 2024-07-31 | Merrill | 10b5-1 | EDGAR |
| 2024-07-30 | Couturier Christophe | Officer | 10,000 | $270.1K | 2024-07-30 | Merrill | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-12
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-12 | 0001628280-26-034146 | EDGAR |
| 2026-04-29 | 0001628280-26-028078 | EDGAR |
| 2026-04-23 | 0001628280-26-026905 | EDGAR |
| 2026-04-01 | 0001628280-26-022575 | EDGAR |
| 2026-02-11 | 0001628280-26-007120 | EDGAR |
| 2025-12-18 | 0001628280-25-057805 | EDGAR |
| 2025-12-04 | 0001722482-25-000221 | EDGAR |
| 2025-11-10 | 0001628280-25-051159 | EDGAR |
| 2025-10-29 | 0001628280-25-046902 | EDGAR |
| 2025-10-14 | 0001628280-25-044871 | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-29 | 0001628280-26-028141 | EDGAR |
| 2025-10-29 | 0001628280-25-046936 | EDGAR |
| 2025-08-01 | 0001722482-25-000190 | EDGAR |
| 2025-04-25 | 0001722482-25-000080 | EDGAR |
| 2024-10-25 | 0001722482-24-000163 | EDGAR |
| 2024-07-26 | 0001722482-24-000145 | EDGAR |
| 2024-04-26 | 0001722482-24-000102 | EDGAR |
| 2023-10-27 | 0001722482-23-000199 | EDGAR |
| 2023-07-28 | 0001722482-23-000159 | EDGAR |
| 2023-04-28 | 0001722482-23-000100 | EDGAR |
ETF Holders
108 ETFs hold AVTR
25 shown · $2.00B total exposure · 0.15% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJH iShares Core S&P Mid-Cap ETF | iShares (BlackRock) | 0.33% | $405.2M | $124.6B | 2026-10-28 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.01% | $323.0M | — | 2026-09-30 |
| 3 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.13% | $229.0M | — | 2026-09-30 |
| 4 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.63% | $174.4M | — | 2026-10-28 |
| 5 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.23% | $149.0M | — | 2026-09-30 |
| 6 | VXF Vanguard Extended Market ETF | Vanguard | 0.12% | $114.7M | — | 2026-09-30 |
| 7 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.30% | $95.5M | — | 2026-10-28 |
| 8 | MDY State Street® SPDR® S&P MIDCAP 400® ETF Trust | SPDR (State Street) | 0.33% | $84.7M | $25.9B | 2026-10-28 |
| 9 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.18% | $61.3M | — | 2026-10-28 |
| 10 | SPMD State Street® SPDR® Portfolio S&P 400™ Mid Cap ETF | SPDR (State Street) | 0.33% | $61.3M | $18.6B | 2026-10-28 |
| 11 | IJJ iShares S&P Mid-Cap 400 Value ETF | iShares (BlackRock) | 0.67% | $57.3M | $8.7B | 2026-10-28 |
| 12 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.08% | $46.8M | $58.8B | 2026-10-28 |
| 13 | VHT Vanguard Health Care ETF | Vanguard | 0.14% | $30.6M | — | 2026-09-30 |
| 14 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.03% | $24.0M | $83.8B | 2026-10-28 |
| 15 | MDYV State Street® SPDR® S&P 400™ Mid Cap Value ETF | SPDR (State Street) | 0.67% | $18.5M | $2.8B | 2026-10-28 |
| 16 | IVOO Vanguard S&P Mid-Cap 400 ETF | Vanguard | 0.30% | $17.0M | — | 2026-09-30 |
| 17 | SCHM Schwab U.S. Mid-Cap ETF | Nport | 0.12% | $16.8M | — | 2026-05-31 |
| 18 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.11% | $15.8M | $15.0B | 2026-10-28 |
| 19 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.02% | $15.7M | — | 2026-10-28 |
| 20 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.02% | $14.8M | $97.2B | 2026-10-28 |
| 21 | BSJS Invesco BulletShares 2028 High Yield Corporate Bond ETF | Invesco | 1.53% | $11.7M | — | 2026-10-28 |
| 22 | IUSV iShares Core S&P U.S. Value ETF | iShares (BlackRock) | 0.04% | $10.0M | $28.7B | 2026-10-28 |
| 23 | IVOV Vanguard S&P Mid-Cap 400 Value ETF | Vanguard | 0.63% | $8.5M | — | 2026-09-30 |
| 24 | VT Vanguard Total World Stock ETF | Vanguard | 0.01% | $8.3M | — | 2026-09-30 |
| 25 | IWB iShares Russell 1000 ETF | iShares (BlackRock) | 0.02% | $7.6M | $48.9B | 2026-10-28 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$0.50
TTM Revenue
$6.64B
TTM Net Income
$337.20M
TTM Op. Cash Flow
$584.70M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q3 '26 | 2026-09-30 | $1.70B | $203.40M | $0.30 | $195.10M |
| Q2 '26 | 2026-06-30 | $1.69B | $38.10M | $0.06 | $178.20M |
| Q1 '26 | 2026-03-31 | $1.58B | $43.30M | $0.06 | $58.70M |
| Q4 '25 | 2025-12-31 | $1.66B | $52.40M | $0.08 | $152.70M |
| Q3 '25 | 2025-09-30 | $1.62B | $-711.80M | $-1.04 | $207.40M |
| Q2 '25 | 2025-06-30 | $1.68B | $64.70M | $0.09 | $154.40M |
| Q1 '25 | 2025-03-31 | $1.58B | $64.50M | $0.09 | $109.30M |
| Q4 '24 | 2024-12-31 | $1.69B | $500.40M | $0.73 | $173.30M |
| Q3 '24 | 2024-09-30 | $1.71B | $57.80M | $0.08 | $244.80M |
| Q2 '24 | 2024-06-30 | $1.70B | $92.90M | $0.14 | $281.10M |
| Q1 '24 | 2024-03-31 | $1.68B | $60.40M | $0.09 | $141.60M |
| Q4 '23 | 2023-12-31 | $1.72B | $98.50M | $0.14 | $251.60M |
Q3 2026 • period ending 2026-09-30 • filed 2026-10-28
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
2.01
P/S
1.73
EV/EBITDA
16.18
EV/Sales
2.24
ROE
-10.3%
ROA
-5.0%
Div Yield
0.00%
FCF Yield
5.27%
Debt/Equity
0.65
Current Ratio
—
Market Cap
$11.33B
as of 2026-10-29
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
39.35M
SI % of Float
6.23%
Days to Cover
4.16
Short Vol Ratio
32.6%
Free Float
631.85M
Float %
93.4%
Short interest 2026-09-30 • Short volume 2026-10-29 • Float 2026-08-14